Status:
COMPLETED
Use of Topical Lidocaine to Reduce Pain in Preterm Infants Receiving Nasal CPAP Continuous Positive Airway Pressure
Lead Sponsor:
Mansoura University Children Hospital
Conditions:
Other Preterm Infants
Eligibility:
All Genders
Up to 28 years
Phase:
PHASE1
Brief Summary
The main purpose of this study is to evaluate the relative efficacy of topical lidocaine on reducing pain associated with the application of nasal CPAP in preterm infants
Detailed Description
Preterm infants admitted to NICUs are exposed to a range of painful procedures. The exposure to pain during this critical of brain development may have adverse consequences. Application of nasal CPAP ...
Eligibility Criteria
Inclusion
- Preterm infants \< 37 weeks gestation
- Admitted to NICU, Mansoura University Children's Hospital
- Respiratory distress requiring use of nasal CPAP
- Informed consent obtained
Exclusion
- Serious, life-threatening malformations
- Use of sedation, analgesia in the preceding 72 hours
- Those who undergo any surgical intervention
- Those who undergo any painful procedures as venipuncture, intubation, suctioning, blood sampling, heel-prick, catheterization 30 minutes before assessment
- Those with signs of nasal injuries at the time of application of nCPAP
- Necrotizing enterocolitis
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02268968
Start Date
October 1 2013
End Date
December 1 2014
Last Update
April 14 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neonatal Intensive Care Unit, Mansoura University Children Hospital
Al Mansurah, Dakahlia Governorate, Egypt, 35516